z-logo
Premium
The spectrum of movement disorders in children with anti‐ NMDA receptor encephalitis
Author(s) -
BaizabalCarvallo José Fidel,
Stocco Amber,
Muscal Eyal,
Jankovic Joseph
Publication year - 2013
Publication title -
movement disorders
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.352
H-Index - 198
eISSN - 1531-8257
pISSN - 0885-3185
DOI - 10.1002/mds.25354
Subject(s) - movement disorders , dystonia , chorea , choreiform movement , blepharospasm , tetrabenazine , encephalitis , athetosis , ataxia , psychology , choreoathetosis , medicine , dyskinesia , neuroscience , pediatrics , immunology , disease , parkinson's disease , virus , dopamine
Background Movement disorders are frequent but difficult to characterize in patients with anti‐ N ‐methyl‐ d ‐aspartate receptor ( NMDAR ) encephalitis. Methods The phenomenology of movement disorders was characterized after a detailed examination of children with anti‐ NMDAR ‐encephalitis. Results We studied 9 children (5 females), ages 3–14 years, with confirmed anti‐ NMDAR ‐encephalitis. All patients presented with at least 1 movement disorder, including chorea (n=4), stereotypic movements (n=4), ataxia (n=3), limb dystonia (n=2), limb myorhythmia (n=2), oromandibular dystonia (n=2), facial myorhythmia, blepharospasm, opisthotonus, athetosis, and tremor (n=1, each). More than a single movement disorder was observed in 6 of these patients. Resolution of the abnormal movements was observed in all patients with immunotherapy; 1 patient improved with tetrabenazine. Conclusions A wide variety of movement disorders, often in combination, can be observed in children with anti‐ NMDAR encephalitis. Patients commonly present with more than a single movement disorder. © 2013 Movement Disorder Society

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom